S&P 500
Nasdaq
Dow Jones
NVDA
AAPL
TSLA
MSFT
BTC-USD
15-min delayed
Live
Home Market News Price Targets Penny Stocks Crypto Economy Commodities Education
Stocks About Contact

ADMA Biologics, Inc.

ADMA XNAS
$8.17 -0.22 (-2.60%) ▼ 15-min delayed
Open
$8.65
High
$8.92
Low
$8.02
Volume
10.21M
Market Cap
$1.89B

About ADMA Biologics, Inc.

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing, and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing, which generates maximum revenue, Plasma Collection Centres, and the corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling & packing services. The company derives maximum revenue from the United States.

Sector: BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) Employees: 647 Website →

Key Financials

Period Revenue Net Income EPS
Q1 2026 $114.49M $45.33M $0.19
FY 2025 $510.17M $146.93M $0.62
Q3 2025 $134.22M $36.43M $0.15
Q2 2025 $121.98M $34.22M $0.14

Earnings & Analyst Ratings

Next Earnings: Tue, Aug 4, 2026
Calendar →

Related Market News

No specific coverage for ADMA yet. Check out our latest market news or earnings calendar.

Get ADMA Alerts

Stay ahead with breaking news, price alerts, and expert analysis on ADMA Biologics, Inc..

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.